Chapleo C B, Myers P L, Butler R C, Doxey J C, Roach A G, Smith C F
J Med Chem. 1983 Jun;26(6):823-31. doi: 10.1021/jm00360a008.
The rational design of RX 781094, 2-(1,4-benzodioxan-2-yl)-2-imidazoline hydrochloride (5), a new potent and selective antagonist of alpha 2-adrenoreceptors, is discussed. A compound that acts as an antagonist at presynaptic alpha 2-adrenoreceptors could be an effective and novel treatment of depression because of its ability to increase the concentration of norepinephrine at central receptor sites. The effects of substituents in the aromatic and imidazoline rings have been examined, as well as the replacement of the imidazoline ring by an amidine function or by other heterocyclic ring systems. None of these derivatives are as potent or selective as 5, although some do display a degree of selectivity as antagonists. Some derivatives were found to possess agonist properties that, with the exception of 23, favored the postsynaptic site. Compounds 9, 12, 16, 21, 30, and 51 possessing presynaptic alpha 2-adrenoreceptor antagonist and postsynaptic alpha 1-adrenoreceptor partial agonist properties were also obtained, and these derivatives could be considered as potential antimigraine agents.
讨论了新型强效选择性α2-肾上腺素能受体拮抗剂RX 781094,即2-(1,4-苯并二氧六环-2-基)-2-咪唑啉盐酸盐(5)的合理设计。一种在突触前α2-肾上腺素能受体上起拮抗剂作用的化合物,因其能够增加中枢受体部位去甲肾上腺素的浓度,可能成为治疗抑郁症的有效新型药物。研究了芳香环和咪唑啉环中取代基的影响,以及用脒官能团或其他杂环系统取代咪唑啉环的情况。这些衍生物均不如5强效或具有选择性,不过有些确实表现出一定程度的作为拮抗剂的选择性。发现一些衍生物具有激动剂特性,除23外,这些特性有利于突触后位点。还获得了具有突触前α2-肾上腺素能受体拮抗剂和突触后α1-肾上腺素能受体部分激动剂特性的化合物9、12、16、21、30和51,这些衍生物可被视为潜在的抗偏头痛药物。